OOIR: Observatory of International Research

Papers

(The H4-Index of Pharmacological Reviews is 40. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Seventy-Five Years of Interactions: The Department of Physiology and Pharmacology at Karolinska Institutet and Pharmacological Reviews	338
The Role of G Protein–Coupled Receptors and Receptor Kinases in Pancreatic β-Cell Function and Diabetes	318
Innovative therapeutics for renoprotection: Where we are	206
Neurobiological Mechanisms of Nicotine Reward and Aversion	140
The Myc Family and the Metastasis Suppressor NDRG1: Targeting Key Molecular Interactions with Innovative Therapeutics	126
Review of Natural Language Processing in Pharmacology	125
The Nitrogen Mustards	120
Metal-based antibody, nanobody, and peptide conjugates: Potential for breast cancer therapy	118
Carbonic anhydrase inhibitors: “Old” drugs with new potential in unexpected areas	117
Therapeutic advantage of combinatorial chimeric antigen receptor T cell and chemotherapies	113
Table of Contents	100
Table of Contents	90
The endocannabinoidomes: Pharmacological redundancy and promiscuity, and multi-kingdom variety of sources and molecular targets	89
Table of Contents	87
Innovation in cancer pharmacotherapy through integrative consideration of germline and tumor genomes	84
Optical Approaches for Investigating Neuromodulation and G Protein–Coupled Receptor Signaling	80
Pharmaceutical perspectives on oligonucleotide therapeutics and delivery systems	80
Elucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins	79
Sex Differences in Opioid and Psychostimulant Craving and Relapse: A Critical Review	78
Pharmacological Modulation of the Crosstalk between Aberrant Janus Kinase Signaling and Epigenetic Modifiers of the Histone Deacetylase Family to Treat Cancer	78
Table of Contents	74
International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily—Update 2023	74
Asthma therapeutics: Past, present, and future	70
The Hippo pathway: Organ size control and beyond	64
G Protein-Coupled Receptor Pharmacology—Insights from Mass Spectrometry	63

Therapeutics in the Pipeline Targeting α-Synuclein for Parkinson's Disease	59
miR-155 aberrant expression impairs tumor rejection due to its targeting of ICOSL and multiple pathways implicated in the anti-tumor response	57
Therapeutic Potential of Targeting Prokineticin Receptors in Diseases	56
Molecular Tweezers: Supramolecular Hosts with Broad-Spectrum Biological Applications	55
Carbon Monoxide Signaling: Examining Its Engagement with Various Molecular Targets in the Context of Binding Affinity, Concentration, and Biologic Response	50
Roles of Individual Human Cytochrome P450 Enzymes in Drug Metabolism	49
Targeting Persistent Changes in Neuroimmune and Epigenetic Signaling in Adolescent Drinking to Treat Alcohol Use Disorder in Adulthood	47
Corrigendum to “International Union of Basic and Clinical Pharmacology. CXIX. Fundamental insights and clinical relevance regarding the carnitine palmitoyltransferase family of enzymes” [Pharmacologic	47
Sulfotransferase 2B1b, Sterol Sulfonation, and Disease	47
Opportunities for Nitric Oxide in Potentiating Cancer Immunotherapy	46
Dopamine, Immunity, and Disease	44
Nonhormonal Male Contraceptive Development—Strategies for Progress	44
Neurobiology of the incubation of drug craving: An update	42
Editorial Board	41
Pharmacological Reviews’ 75th Year Anniversary: Past and Future—Editorial	41